Anlon Healthcare Limited has announced a comprehensive postal ballot seeking shareholder approval for several significant corporate actions, including a stock split, authorized capital increase, and bonus share issue. The company has set the remote e-voting period from March 10, 2026 to April 08, 2026, with March 06, 2026 as the cut-off date for eligible shareholders.

Stock Split Proposal

The company proposes to subdivide every 1 equity share having face value of Rs.10 into 5 equity shares of Rs.2 each. This stock split aims to enhance liquidity in the company's equity shares and encourage greater participation by retail investors and small potential investors.

Authorized Capital Increase

Following the stock split, the company seeks to double its authorized share capital from Rs.55,00,00,000 to Rs.1,10,00,00,000 by creating additional 27,50,00,000 equity shares of Rs.2 each. This increase will facilitate the proposed bonus issue and provide flexibility for future capital requirements.

Bonus Share Issue

The Board of Directors has recommended issuing bonus shares in the ratio of 1:1, meaning shareholders will receive 1 new fully paid-up equity share of Rs.2 for every 1 existing share held. The bonus issue will be funded by capitalizing up to Rs.53,15,15,000 from the company's securities premium and/or free reserves.

E-Voting Process and Timeline

The postal ballot will be conducted entirely through remote e-voting, with no physical ballot forms being distributed. Shareholders can cast their votes through the e-voting platform provided by KFin Technologies Limited.

Corporate Governance and Compliance

M/s. K.P. Ghelani and Associates, Company Secretary in Practice, has been appointed as the Scrutinizer to conduct the postal ballot process in a fair and transparent manner. The company confirms compliance with all regulatory requirements under the Companies Act, 2013, and SEBI regulations.

The Board of Directors approved these proposals at their meeting held on March 06, 2026, recommending them as being in the best interest of shareholders. The company has confirmed that it has not defaulted on any statutory payments including employee dues, fixed deposits, or debt securities.

Rationale and Benefits

According to the explanatory statement, these corporate actions reflect the company's strong financial position and positive growth outlook. The stock split is expected to make shares more affordable for retail investors, while the bonus issue rewards existing shareholders and demonstrates confidence in the company's future prospects. Anlon Healthcare was incorporated in 2013 and got listed on BSE and NSE in 2025, showing consistent growth in business operations and financial performance.

Anlon Healthcare has successfully concluded its board meeting on March 6, 2026, approving comprehensive corporate restructuring measures including a 1:5 stock split and 1:1 bonus share issuance. The board meeting, held at the company's registered office, commenced at 12:00 p.m. IST and concluded at 01:00 p.m. IST.

Board Approved Corporate Actions

The company has formalized its capital restructuring plan with specific implementation details that will significantly impact shareholders and enhance market accessibility. The proposed corporate actions are aimed at enhancing liquidity of the company's equity shares and enabling higher participation from public shareholders.

Stock Split Implementation Details

The approved 1:5 stock split will subdivide each existing equity share having face value of Rs.10 into 5 equity shares with face value of Rs.2 each. The current paid-up capital of Rs.53,15,15,000 comprising 5,31,51,500 shares will transform into 26,57,57,500 shares post-subdivision, maintaining the same total capital value.

Bonus Share Allocation

The board has approved issuing bonus equity shares in a 1:1 ratio, meaning shareholders will receive 1 bonus equity share of Rs.2 each for every 1 equity share held as on the record date. The bonus issue will utilize Rs.53,15,15,000 from the company's free reserves, which stood at Rs.147.08 crore as on December 31, 2025.

Capital Structure Post Implementation

Following the completion of both corporate actions, the company's authorized share capital will increase to Rs.1,10,00,00,000, divided into 55,00,00,000 equity shares of Rs.2 each. The paid-up capital will double to Rs.1,06,30,30,000 comprising 53,15,15,000 equity shares.

Regulatory Compliance and Next Steps

The company has appointed M/s. K.P. Ghelani & Associates, Practicing Company Secretaries, as scrutinizer for conducting the postal ballot and e-voting process. The board has also approved the postal ballot notice for seeking member approval and other statutory requirements. All corporate actions are subject to member approval and completion of applicable statutory requirements within the estimated 2-month timeline.